BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 9570036)

  • 21. ER chaperone functions during normal and stress conditions.
    Ma Y; Hendershot LM
    J Chem Neuroanat; 2004 Sep; 28(1-2):51-65. PubMed ID: 15363491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein quality control, retention, and degradation at the endoplasmic reticulum.
    Benyair R; Ron E; Lederkremer GZ
    Int Rev Cell Mol Biol; 2011; 292():197-280. PubMed ID: 22078962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
    Apodaca J; Kim I; Rao H
    Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycan regulation of ER-associated degradation through compartmentalization.
    Benyair R; Ogen-Shtern N; Lederkremer GZ
    Semin Cell Dev Biol; 2015 May; 41():99-109. PubMed ID: 25460542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of endoplasmic reticulum-associated degradation using yeast membranes and cytosol.
    Lee RJ; McCracken AA; Brodsky JL
    Methods Mol Biol; 2005; 301():175-84. PubMed ID: 15917632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Golgi-mediated vacuolar sorting of the endoplasmic reticulum chaperone BiP may play an active role in quality control within the secretory pathway.
    Pimpl P; Taylor JP; Snowden C; Hillmer S; Robinson DG; Denecke J
    Plant Cell; 2006 Jan; 18(1):198-211. PubMed ID: 16339854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co- and Post-Translational Protein Folding in the ER.
    Ellgaard L; McCaul N; Chatsisvili A; Braakman I
    Traffic; 2016 Jun; 17(6):615-38. PubMed ID: 26947578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant quality control in the endoplasmic reticulum impairs the biosynthesis of pulmonary surfactant in mice expressing mutant BiP.
    Mimura N; Hamada H; Kashio M; Jin H; Toyama Y; Kimura K; Iida M; Goto S; Saisho H; Toshimori K; Koseki H; Aoe T
    Cell Death Differ; 2007 Aug; 14(8):1475-85. PubMed ID: 17464327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
    Sawkar AR; Schmitz M; Zimmer KP; Reczek D; Edmunds T; Balch WE; Kelly JW
    ACS Chem Biol; 2006 May; 1(4):235-51. PubMed ID: 17163678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41.
    Sevilla LM; Comstock SS; Swier K; Miller J
    J Immunol; 2004 Aug; 173(4):2586-93. PubMed ID: 15294975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced binding to the molecular chaperone BiP slows thyroglobulin export from the endoplasmic reticulum.
    Muresan Z; Arvan P
    Mol Endocrinol; 1998 Mar; 12(3):458-67. PubMed ID: 9514162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum quality control and apoptosis.
    Groenendyk J; Michalak M
    Acta Biochim Pol; 2005; 52(2):381-95. PubMed ID: 15933766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Quality Control in the Endoplasmic Reticulum.
    Adams BM; Oster ME; Hebert DN
    Protein J; 2019 Jun; 38(3):317-329. PubMed ID: 31004255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.
    Tsukuba T; Kadowaki T; Hengst JA; Bond JS
    Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biological and chemical basis for tissue-selective amyloid disease.
    Sekijima Y; Wiseman RL; Matteson J; Hammarström P; Miller SR; Sawkar AR; Balch WE; Kelly JW
    Cell; 2005 Apr; 121(1):73-85. PubMed ID: 15820680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRP94 in ER quality control and stress responses.
    Eletto D; Dersh D; Argon Y
    Semin Cell Dev Biol; 2010 Jul; 21(5):479-85. PubMed ID: 20223290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human β-glucocerebrosidase.
    Babajani G; Kermode AR
    Plant Signal Behav; 2014; 9(3):e28714. PubMed ID: 24713615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.